Your browser doesn't support javascript.
loading
Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria.
Erameh, Cyril; Edeawe, Osahogie; Akhideno, Peter; Eifediyi, Gloria; Omansen, Till F; Wagner, Christine; Sarpong, Francisca; Koch, Till; Wicha, Sebastian; Kurth, Florian; Duraffour, Sophie; Oestereich, Lisa; Pahlmann, Meike; Okogbenin, Sylvanus; Ogbaini-Emovon, Ephraim; Günther, Stephan; Ramharter, Michael; Groger, Mirjam.
Afiliación
  • Erameh C; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Edeawe O; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Akhideno P; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Eifediyi G; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Omansen TF; Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Wagner C; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Sarpong F; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Koch T; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wicha S; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kurth F; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Duraffour S; Department of Clinical Pharmacology, University of Hamburg, Hamburg, Germany.
  • Oestereich L; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pahlmann M; Department of Infectious Diseases and Pulmonary Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Okogbenin S; Department of Virology, Bernhard-Nocht-Institut fur Tropenmedizin, Hamburg, Germany.
  • Ogbaini-Emovon E; Department of Virology, Bernhard-Nocht-Institut fur Tropenmedizin, Hamburg, Germany.
  • Günther S; Department of Virology, Bernhard-Nocht-Institut fur Tropenmedizin, Hamburg, Germany.
  • Ramharter M; Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
  • Groger M; Department of Obstetrics and Gynaecology, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
BMJ Open ; 10(4): e036936, 2020 04 16.
Article en En | MEDLINE | ID: mdl-32303517
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ribavirina / Fiebre de Lassa Tipo de estudio: Guideline / Observational_studies Aspecto: Ethics Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2020 Tipo del documento: Article País de afiliación: Nigeria Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ribavirina / Fiebre de Lassa Tipo de estudio: Guideline / Observational_studies Aspecto: Ethics Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2020 Tipo del documento: Article País de afiliación: Nigeria Pais de publicación: Reino Unido